44 results on '"Waluś-Miarka, Małgorzata"'
Search Results
2. Associations of lipoprotein(a) concentrations with cardiovascular disease in men and women with primary hypercholesterolemia
3. Carotid artery plaques – Are risk factors the same in men and women with familial hypercholesterolemia?
4. Targeted sequencing of a gene panel in patients with Familial Hypercholesterolemia from Southern Poland
5. Effectiveness and safety of PCSK9 inhibitor therapy in patients with familial hypercholesterolemia within a therapeutic program in Poland: Preliminary multicenter data
6. Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes
7. A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland
8. Corticosteroid treatment of kidney disease in a patient with familial lecithin-cholesterol acyltransferase deficiency
9. Ogólna patogeneza przewlekłych powikłań cukrzycy. [W : epidemiologia i ogólna patogeneza przewlekłych powikłań cukrzycy]
10. Correlates of pentraxin 3 serum concentration in men and women with type 2 diabetes
11. The genetic spectrum of familial hypercholesterolemia in south-eastern Poland
12. Pentraxin 3 in patients with type 2 diabetes and nonalcoholic fatty liver disease: a promising treatment target for glucagon-like peptide-1 receptor agonists. Authors' reply
13. Serum pentraxin 3 concentration in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
14. Correlates of pentraxin 3 serum concentration in men and women with type 2 diabetes.
15. The genetic spectrum of familial hypercholesterolemia in south-eastern Poland
16. Zaburzenia lipidowe w cukrzycy
17. Ogólna patogeneza przewlekłych powikłań cukrzycy
18. Leczenie zaburzeń lipidowych w cukrzycy
19. Serum pentraxin 3 concentration in patients with type 2 diabetes and nonalcoholic fatty liver disease.
20. Determinants of nonalcoholic fatty liver disease in men and women with type 2 diabetes
21. Is now the time for probiotics in diabetes management?
22. Is there a progress in treatment of dyslipidemia in diabetes? : what are the results of ACCORD study?
23. Carotid Plaques Correlates in Patients With Familial Hypercholesterolemia
24. Refinement of Variant Selection for the LDL Cholesterol Genetic Risk Score in the Diagnosis of the Polygenic Form of Clinical Familial Hypercholesterolemia and Replication in Samples from 6 Countries
25. Influence of growth and inflammatory factors on the development of nephropathy in patients with diabetes mellitus type 2
26. Autosomal dominant hypercholesterolemia : underrecognised diagnostic and clinical problem
27. Algorithms in the management of lipid disorders in diabetes
28. Pentraxin 3 concentration is positively associated with apo C3 and abdominal obesity in men with type 2 diabetes
29. Pentraxin 3 concentration in patients with type 2 diabetes mellitus and NAFLD
30. Arterial wave velocity and coronary risk factors in patients with type 2 diabetes
31. High density lippoproteins and atherosclerosis
32. Vitamin D receptor gene polymorphisms and the risk of coronary artery disease in a Polish population with type 2 diabetes mellitus and with normal glucose metabolism
33. Homocysteine and C-reactive protein concentrations in diabetic patients serum
34. Intima–media thickness correlates with features of metabolic syndrome in young people with a clinical diagnosis of familial hypercholesterolaemia
35. Carotid Plaques Correlates in Patients With Familial Hypercholesterolemia.
36. A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland
37. Osteoprotegerin is associated with markers of atherosclerosis and body fat mass in type 2 diabetes patients
38. Authors' reply.
39. Aortic valve and arterial calcification in patients with familial hypercholesterolemia.
40. Is now the time for probiotics in diabetes management?
41. [Determinants of nonalcoholic fatty liver disease in men and women with type 2 diabetes].
42. Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes.
43. [Autosomal dominant hypercholesterolemia - underrecognised diagnostic and clinical problem].
44. [Arterial wave velocity and coronary risk factors in patients with type-2 diabetes].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.